SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-005756
Filing Date
2023-04-03
Accepted
2023-04-03 16:07:40
Documents
2
Period of Report
2023-03-30

Document Format Files

Seq Description Document Type Size
1 form3-04032023_080434.html 3  
1 form3-04032023_080434.xml 3 1725
2 ex24-04032023_080434.htm EX-24 8757
  Complete submission text file 0001415889-23-005756.txt   11803
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XILIO THERAPEUTICS, INC. 828 WINTER STREET WALTHAM MA 02451
Business Address
Brennan Kevin M. (Reporting) CIK: 0001971303 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40925 | Film No.: 23792670